Wallach, J; Kang, H; Colestock, T; Morris, H; Bortolotto, ZA; Collingridge, GL; Lodge, D; Halberstadt, AL; Brandt, SD; Adejare, A. Pharmacological investigations of the dissociative “Legal Highs” diphenidine, methoxphenidine and analogues PLOS ONE, 17 Jun 2016, 11 (6), e0157021. 8.9 MB. https://doi.org/10.1371/journal.pone.0157021 #3-MeO-PCP GC,MS,NMR
Wallach, J; De Paoli, G; Adejare, A; Brandt, SD. Preparation and analytical characterization of 1-(1-phenylcyclohexyl)piperidine (PCP) and 1-(1-phenylcyclohexyl)pyrrolidine (PCPy) analogues Drug Test. Anal., 1 Jul 2014, 6 (7-8), 633-650. 874 kB. https://doi.org/10.1002/dta.1468 #4a GC,MS,NMR
Morris, H; Wallach, J. From PCP to MXE: A comprehensive review of the non-medical use of dissociative drugs Drug Test. Anal., 1 Jul 2014, 6 (7-8), 614-632. 942 kB. https://doi.org/10.1002/dta.1620 #3-MeO-PCP
adder. PCP analogs (cumulative) Bluelight, 20 May 2010. 792 kB. #3′-MeO-PCP From bluelight.org PCP analogs (Cumulative)
EMCDDA. New drugs in Europe, 2012, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2013. 773 kB. #21
EMCDDA. New drugs in Europe, 2014, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2015. 879 kB.
EMCDDA. New drugs in Europe, 2011, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Apr 2012. 401 kB.
Roth, BL; Gibbons, S; Arunotayanun, W; Huang, X; Setola, V; Treble, R; Iversen, L. The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor PLoS ONE, 19 Mar 2013, 8 (3), e59334. 453 kB. https://doi.org/10.1371/journal.pone.0059334 #3-MeO-PCP
Wallach, JV. Structure activity relationship (SAR) studies of arylcycloalkylamines as N-methyl-D-aspartate receptor antagonists Ph. D. Thesis, 19 Dec 2014. #1b
Kalir, A. Structure activity relationships of phencyclidine derivatives In PCP (phencyclidine), historical and current perspectives; Domino, EF, Ed., NPP Books, Ann Arbor, MI, 1 Jan 1981; pp 31–46. 2.3 MB.
Wallach, J; Brandt, SD. Phencyclidine-based new psychoactive substances In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 261-303. 515 kB. https://doi.org/10.1007/164_2018_124 #3-MeO-PCP
De Paoli, G; Brandt, SD; Wallach, J; Archer, RP; Pounder, DJ. From the street to the laboratory: Analytical profiles of methoxetamine, 3-methoxyeticyclidine and 3-methoxyphencyclidine and their determination in three biological matrices J. Anal. Toxicol., 1 Jun 2013, 37 (5), 277–283. 264 kB. https://doi.org/10.1093/jat/bkt023 #3-MeO-PCP GC,LC,MS,NMR,UV
Dimitrov, I; Denny, W; Jose, J. Syntheses of ketamine and related analogues: A mini review Synthesis, 1 Nov 2018, 50 (21), 4201–4215. 793 kB. https://doi.org/10.1055/s-0037-1609935 #81
Kraemer, M; Boehmer, A; Madea, B; Maas, A. Death cases involving certain new psychoactive substances: A review of the literature Forensic Sci. Int., 1 May 2019, 298, 186–267. 6.7 MB. https://doi.org/10.1016/j.forsciint.2019.02.021 #3-MeO-PCP
Bertron, JL; Seto, M; Lindsley, CW. DARK classics in chemical neuroscience: Phencyclidine (PCP) ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2459-2474. 9.9 MB. https://doi.org/10.1021/acschemneuro.8b00266 #29
Åstrand, A; Guerrieri, D; Vikingsson, S; Kronstrand, R; Green, H. In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT1A, and 5-HT2A receptors—On-target receptor potency and efficacy, and off-target effects Forensic Sci. Int., 1 Dec 2020, 317, 110553. 1.7 MB. https://doi.org/10.1016/j.forsciint.2020.110553 #3-methoxyphencyclidine (3-MeO-PC
WHO. WHO Expert Committee on Drug Dependence: Forty-third Report World Health Organization, 1 Jan 2021. 1.9 MB. #3-MeO-PCP
Zarantonello, P; Bettini, E; Paio, A; Simoncelli, C; Terreni, S; Cardullo, F. Novel analogues of ketamine and phencyclidine as NMDA receptor antagonists Bioorg. Med. Chem. Lett., 1 Apr 2011, 21 (7), 2059–2063. 594 kB. https://doi.org/10.1016/j.bmcl.2011.02.009 #3